Phase III study of perioperative pembrolizumab (pembro) plus neoadjuvant chemotherapy (chemo) versus placebo plus neoadjuvant chemo in cisplatin-eligible patients (pts) with muscle-invasive bladder cancer (MIBC): KEYNOTE-866.
暂无分享,去创建一个
H. Nishiyama | G. Steinberg | A. Siefker-Radtke | J. Bedke | B. H. Moreno | C. Hoimes | R. Kataria | Xiao-hong Fang